Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial.
Sharp A, Cornforth C, Jackson R, Harrold J, Turner MA, Kenny LC, Baker PN, Johnstone ED, Khalil A, von Dadelszen P, Papageorghiou AT, Alfirevic Z; STRIDER group. Sharp A, et al. Among authors: turner ma. Lancet Child Adolesc Health. 2018 Feb;2(2):93-102. doi: 10.1016/S2352-4642(17)30173-6. Epub 2017 Dec 7. Lancet Child Adolesc Health. 2018. PMID: 30169244 Free article. Clinical Trial.
Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction.
Sharp A, Cornforth C, Jackson R, Harrold J, Turner MA, Kenny L, Baker PN, Johnstone ED, Khalil A, von Dadelszen P, Papageorghiou AT, Alfirevic Z. Sharp A, et al. Among authors: turner ma. Lancet Child Adolesc Health. 2019 Mar;3(3):e2-e3. doi: 10.1016/S2352-4642(19)30020-3. Epub 2019 Jan 29. Lancet Child Adolesc Health. 2019. PMID: 30704877 No abstract available.
A prediction model for short-term neonatal outcomes in severe early-onset fetal growth restriction.
Sharp A, Jackson R, Cornforth C, Harrold J, Turner MA, Kenny L, Baker PN, Johnstone ED, Khalil A, von Dadelszen P, Papageorghiou AT, Alfirevic Z. Sharp A, et al. Among authors: turner ma. Eur J Obstet Gynecol Reprod Biol. 2019 Oct;241:109-118. doi: 10.1016/j.ejogrb.2019.08.007. Epub 2019 Aug 16. Eur J Obstet Gynecol Reprod Biol. 2019. PMID: 31499415 Clinical Trial.
Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial.
Hill LF, Clements MN, Turner MA, Donà D, Lutsar I, Jacqz-Aigrain E, Heath PT, Roilides E, Rawcliffe L, Alonso-Diaz C, Baraldi E, Dotta A, Ilmoja ML, Mahaveer A, Metsvaht T, Mitsiakos G, Papaevangelou V, Sarafidis K, Walker AS, Sharland M; NeoVanc Consortium. Hill LF, et al. Among authors: turner ma. Lancet Child Adolesc Health. 2022 Jan;6(1):49-59. doi: 10.1016/S2352-4642(21)00305-9. Epub 2021 Nov 26. Lancet Child Adolesc Health. 2022. PMID: 34843669 Free PMC article. Clinical Trial.
The WHEAT pilot trial-WithHolding Enteral feeds Around packed red cell Transfusion to prevent necrotising enterocolitis in preterm neonates: a multicentre, electronic patient record (EPR), randomised controlled point-of-care pilot trial.
Gale C, Modi N, Jawad S, Culshaw L, Dorling J, Bowler U, Forster A, King A, McLeish J, Linsell L, Turner MA, Robberts H, Stanbury K, van Staa T, Juszczak E. Gale C, et al. Among authors: turner ma. BMJ Open. 2019 Sep 20;9(9):e033543. doi: 10.1136/bmjopen-2019-033543. BMJ Open. 2019. PMID: 31542771 Free PMC article.
Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants.
Lowe J, Gillespie D, Hubbard M, Zhang L, Kirby N, Pickles T, Thomas-Jones E, Turner MA, Klein N, Marchesi JR, Hood K, Berrington J, Kotecha S. Lowe J, et al. Among authors: turner ma. BMJ Open. 2020 Oct 6;10(10):e041528. doi: 10.1136/bmjopen-2020-041528. BMJ Open. 2020. PMID: 33028566 Free PMC article.
482 results